Clinical Trial Update: Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating carvedilol extended-release for biomarkers in blood and urine and safety in patients with heart failure with preserved ejection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Carvedilol SR (carvedilol)

Snippet

Sponsor: Yonsei University | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: UNKNOWN